Delivery Order SPE2DB20D2104-SPE2DB24FU96L
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of XIFAXAN 550 MG TABLET 60S. The contract has a ceiling value of $1,638.32 and is a firm fixed price arrangement. The award was made by the Defense Logistics Agency (DLA), a defense agency, on June 26, 2025, with a period of performance through June 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award is a Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract has a Ceiling Value of $5,824.21 and is a Firm Fixed Price arrangement. The contract is not set-aside and was awarded on June 12, 2025, with a completion date of June 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order worth $11,191.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a completion date of May 22, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award is a delivery order with a firm fixed price valued at $2,127.35, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a period of performance through May 28, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
This federal contract award, valued at $11,624.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2024 and is a firm fixed-price delivery order. This award is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract, valued at $3,508.05, was awarded to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division on June 6, 2024. The award is a Delivery Order under a Firm Fixed Price contract type, with an ultimate completion date of June 7, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the larger...
This federal contract award is a delivery order for XIFAXAN 550 MG TABLET 60S, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $14,008.15 firm fixed-price contract has a completion date of May 22, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of XIFAXAN 550 MG TABLET 60S. The contract has a ceiling value of $17,572.67 and runs through May 30, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,525.09 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. This delivery order is part of a broader Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order with a Firm Fixed Price, is for the supply of XIFAXAN 550 mg tablets and has a ceiling value of $10,048.20. The contract has an ultimate completion date of January 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...